| Title |
Long-Term Statin Use and Risk of Ductal and Lobular Breast Cancer among Women 55 to 74 Years of Age
|
|---|---|
| Published in |
Cancer Epidemiology, Biomarkers & Prevention, September 2013
|
| DOI | 10.1158/1055-9965.epi-13-0414 |
| Pubmed ID | |
| Authors |
Jean A. McDougall, Kathleen E. Malone, Janet R. Daling, Kara L. Cushing-Haugen, Peggy L. Porter, Christopher I. Li |
| Abstract |
Mechanistic studies largely support the chemopreventive potential of statins. However, results of epidemiologic studies investigating statin use and breast cancer risk have been inconsistent and lacked the ability to evaluate long-term statin use. |
X Demographics
The data shown below were collected from the profiles of 205 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 62 | 30% |
| United Kingdom | 31 | 15% |
| Canada | 10 | 5% |
| Australia | 5 | 2% |
| Venezuela, Bolivarian Republic of | 5 | 2% |
| South Africa | 4 | 2% |
| New Zealand | 4 | 2% |
| Ireland | 4 | 2% |
| Brazil | 3 | 1% |
| Other | 16 | 8% |
| Unknown | 61 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 135 | 66% |
| Practitioners (doctors, other healthcare professionals) | 53 | 26% |
| Scientists | 12 | 6% |
| Science communicators (journalists, bloggers, editors) | 5 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 1 | 1% |
| Denmark | 1 | 1% |
| Italy | 1 | 1% |
| Unknown | 65 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 13 | 19% |
| Other | 10 | 15% |
| Researcher | 10 | 15% |
| Student > Bachelor | 9 | 13% |
| Student > Postgraduate | 6 | 9% |
| Other | 11 | 16% |
| Unknown | 9 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 44% |
| Biochemistry, Genetics and Molecular Biology | 9 | 13% |
| Agricultural and Biological Sciences | 3 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Computer Science | 1 | 1% |
| Other | 9 | 13% |
| Unknown | 14 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 242. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2024.
All research outputs
#156,462
of 25,639,676 outputs
Outputs from Cancer Epidemiology, Biomarkers & Prevention
#62
of 4,857 outputs
Outputs of similar age
#998
of 209,676 outputs
Outputs of similar age from Cancer Epidemiology, Biomarkers & Prevention
#3
of 50 outputs
Altmetric has tracked 25,639,676 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,857 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,676 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.